Literature DB >> 23512774

Effect of freeze dried bovine amniotic membrane extract on full thickness wound healing.

Mirin Kang1, Seoyoung Choi, Ae-Ri Cho Lee.   

Abstract

This study explored the feasibility of development of solubilized amniotic membrane extract (AME) as a potential wound healing substrate with improved efficacy. Bovine amniotic membrane was extracted using a mixture of acetic acid and 2-mercaptopropionic acid under sonication, which was followed by the frozen, and then lyophilized processes. The effects of AME on cell migration and growth properties were evaluated from 0 to 24 h of post injury using primary human foreskin fibroblast monolayer culture with one line scratch as an in vitro wound model. Its wound healing efficacy and scar preventive effects were investigated using whole thickness biopsy punch (8 mm) wound model obtained from rabbit ear. Intra dermal injections of AME fluid (10 μl of 1.2 μg/μl) on four wound sites were performed at 1 h pre injury, post 1, 2 and 3 day. The processes and levels of re-epithelialization and dermal regeneration were examined through histological assessment with H-E staining. In cell migration study conducted at 24 h post injury, AME (1.7 μg/ml) treated cells significantly increased wound closure with 54.9 % compared to control. Histological image analysis on AME treated wound sites at 36 days post injury showed properly developed epidermal basal cell layers and weave-like dermal collagen bundles, whereas those of untreated control skin showed over-proliferation of epidermis and aggregated collagen bundles with defected dermal regeneration. The results of this study verified the feasibility of dermal injections of freeze dried AME as a potential wound healing substrate which can promote epidermal and dermal regeneration, while avoiding undesirable hyper-proliferation of damaged tissue.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23512774     DOI: 10.1007/s12272-013-0079-5

Source DB:  PubMed          Journal:  Arch Pharm Res        ISSN: 0253-6269            Impact factor:   4.946


  7 in total

Review 1.  Applied Bioengineering in Tissue Reconstruction, Replacement, and Regeneration.

Authors:  Juan M Colazo; Brian C Evans; Angel F Farinas; Salam Al-Kassis; Craig L Duvall; Wesley P Thayer
Journal:  Tissue Eng Part B Rev       Date:  2019-08       Impact factor: 6.389

Review 2.  Preparation of placental tissue transplants and their application in skin wound healing and chosen skin bullous diseases - Stevens-Johnson syndrome and toxic epidermal necrolysis treatment.

Authors:  Agnieszka Klama-Baryła; Ewa Rojczyk; Diana Kitala; Wojciech Łabuś; Wojciech Smętek; Katarzyna Wilemska-Kucharzewska; Marek Kucharzewski
Journal:  Int Wound J       Date:  2020-01-15       Impact factor: 3.315

3.  Differential effects of amnion and chorion membrane extracts on osteoblast-like cells due to the different growth factor composition of the extracts.

Authors:  Yoon Young Go; Sung Eun Kim; Geum Joon Cho; Sung-Won Chae; Jae-Jun Song
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 4.  Biomaterials and Nanotherapeutics for Enhancing Skin Wound Healing.

Authors:  Subhamoy Das; Aaron B Baker
Journal:  Front Bioeng Biotechnol       Date:  2016-10-31

Review 5.  Amniotic membrane extract and eye drops: a review of literature and clinical application.

Authors:  Michael S Murri; Majid Moshirfar; Orry C Birdsong; Yasmyne C Ronquillo; Yanning Ding; Phillip C Hoopes
Journal:  Clin Ophthalmol       Date:  2018-06-18

6.  Human Acellular Amniotic Matrix with Previously Seeded Umbilical Cord Mesenchymal Stem Cells Restores Endometrial Function in a Rat Model of Injury.

Authors:  Shan Wang; Cheng Shi; Xiaohui Cai; Yanbin Wang; Xi Chen; Hongjing Han; Huan Shen
Journal:  Mediators Inflamm       Date:  2021-09-03       Impact factor: 4.711

7.  Human Amniotic Membrane Enriched with Urinary Bladder Fibroblasts Promote the Re-Epithelization of Urothelial Injury.

Authors:  Urška Dragin Jerman; Peter Veranič; Tina Cirman; Mateja Erdani Kreft
Journal:  Cell Transplant       Date:  2020 Jan-Dec       Impact factor: 4.064

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.